Skip to main content

datastreet.in

Alkem MedTech to acquire 55% stake in Occlutech for €99.4 million

Alkem Laboratories’ devices arm to acquire controlling stake in Swiss cardiac implant maker, marking entry into global structural heart segment

Source :- Companies Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *